MedPath

Caffeine

Generic Name
Caffeine
Brand Names
Anacin, Arthriten Inflammatory Pain, Ascomp, Bc Arthritis, Bc Original Formula, Cafcit, Diurex, Dvorah, Esgic, Exaprin, Excedrin, Excedrin Tension Headache, Fioricet, Fioricet With Codeine, Fiorinal, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Midol Complete, Midol Cramps & Bodyaches, Migergot, Norgesic, Norgesic Forte, Orbivan, Orphengesic, Pamprin Max Formula, Peyona, Stanback Headache Powder Reformulated Jan 2011, Trezix, Trianal, Trianal C, Triatec, Triatec-8, Vanatol, Vanatol S, Vanquish, Vivarin, Peyona (previously Nymusa), Gencebok
Drug Type
Small Molecule
Chemical Formula
C8H10N4O2
CAS Number
58-08-2
Unique Ingredient Identifier
3G6A5W338E
Background

Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to Theophylline and Theobromine. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.

The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.

Indication

Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.

Associated Conditions
Acute Pain, Chronic Lung Disease of Prematurity, Common Cold, Dyspepsia, Fatigue, Fever, Flu caused by Influenza, Headache, Menstrual Pain, Myalgia, Pain, Pain caused by Rheumatism, Primary apnea of premature newborns, Respiratory Depression, Somnolence, Tension Headache, Toothache, Under-eyes Dark Circles, Vascular Headaches, Moderate Pain
Associated Therapies
Analgesia, Antacid therapy, Athletic Performance

Influence of Caffeine Consumption on the Human Circadian System

Not Applicable
Completed
Conditions
Caffeine
Circadian Rhythm
Caffeine Withdrawal
Sleep
Interventions
Drug: Caffeine
Drug: Placebo
First Posted Date
2022-06-08
Last Posted Date
2022-06-08
Lead Sponsor
Psychiatric Hospital of the University of Basel
Target Recruit Count
20
Registration Number
NCT05409339
Locations
🇨🇭

UPK Basel, Basel, Basel Stadt, Switzerland

Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2021-11-16
Last Posted Date
2022-01-05
Lead Sponsor
Abivax S.A.
Target Recruit Count
59
Registration Number
NCT05121714
Locations
🇬🇧

Simbec-Orion, Merthyr Tydfil, United Kingdom

A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants

Phase 1
Completed
Conditions
Healthy Participants
Interventions
First Posted Date
2021-10-05
Last Posted Date
2024-05-31
Lead Sponsor
Pfizer
Target Recruit Count
26
Registration Number
NCT05067439
Locations
🇺🇸

Research Centers of America ( Hollywood ), Hollywood, Florida, United States

Caffeine and Cerebrovascular Reactivity

Early Phase 1
Completed
Conditions
Caffeine
Interventions
Drug: Placebo
Drug: Caffeine
First Posted Date
2021-01-29
Last Posted Date
2022-08-09
Lead Sponsor
University of Oklahoma
Target Recruit Count
10
Registration Number
NCT04730193
Locations
🇺🇸

Translational GeroScience Laboratory, Oklahoma City, Oklahoma, United States

Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants

Phase 1
Completed
Conditions
Healthy Participants
Interventions
Drug: Caffeine
Other: Ritlecitinib
First Posted Date
2020-12-04
Last Posted Date
2021-03-18
Lead Sponsor
Pfizer
Target Recruit Count
12
Registration Number
NCT04655040
Locations
🇺🇸

New Haven Clinical Research Unit, New Haven, Connecticut, United States

Drug-drug Interaction Study of KL1333 in Healthy Subjects

First Posted Date
2020-11-25
Last Posted Date
2021-10-20
Lead Sponsor
Abliva AB
Target Recruit Count
14
Registration Number
NCT04643249
Locations
🇬🇧

Volunteer recruitment center Covance Leeds Covance Leeds, Leeds, United Kingdom

Effect of CAFfeine on Cognition in Alzheimer's Disease

Phase 3
Recruiting
Conditions
Alzheimer Disease
Interventions
Drug: Caffeine
Drug: Placebo
First Posted Date
2020-09-30
Last Posted Date
2022-03-02
Lead Sponsor
University Hospital, Lille
Target Recruit Count
248
Registration Number
NCT04570085
Locations
🇫🇷

CH Béthune, Béthune, France

🇫🇷

CHU Caen, Caen, France

🇫🇷

CHU Amiens, Amiens, France

and more 14 locations

Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

First Posted Date
2020-08-07
Last Posted Date
2022-06-16
Lead Sponsor
University of Southern Denmark
Target Recruit Count
10
Registration Number
NCT04504045
Locations
🇩🇰

University of Southern Denmark, Odense, Region Of Southern Denmark, Denmark

Caffeine Study for Pain Control Following Total Joint Replacement

Not Applicable
Conditions
Pain, Postoperative
Interventions
Drug: Caffeine
Drug: Placebo oral tablet
First Posted Date
2020-02-21
Last Posted Date
2020-10-19
Lead Sponsor
Rothman Institute Orthopaedics
Target Recruit Count
70
Registration Number
NCT04280263
Locations
🇺🇸

Rothman Orthopaedics at Egg Harbor Township, Egg Harbor Township, New Jersey, United States

Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4

Phase 1
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2020-01-29
Last Posted Date
2024-08-15
Lead Sponsor
R-Pharm International, LLC
Target Recruit Count
17
Registration Number
NCT04246762
Locations
🇧🇬

Comac Medical Ltd, Sofia, Bulgaria

🇲🇩

ICS ARENSIA Exploratory Medicine SRL, a daughter company of ARENSIA Exploratory Medicine GmbH,Republican Clinical Hospital, Chisinau, Moldova, Republic of

© Copyright 2025. All Rights Reserved by MedPath